SCHEMBL26092162

SCHEMBL26092162

O=CC(=O)C1CCC(N2Cc3c(cc(F)c(F)c3N3C4CNCC3C4)C2=O)CN1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26093856 0.94 MAPK1 (0.31) MAPK1
SCHEMBL26092619 0.90 MAPK1 (0.32) MAPK1
SCHEMBL26133298 0.88 MAPK1 (0.35) MAPK1
SCHEMBL26092265 0.85 CHRNB2 (0.32) MAPK1
SCHEMBL26094140 0.85 MAPK1 (0.30) MAPK1
SCHEMBL26094331 0.84 MAPK1 (0.33) MAPK1
SCHEMBL26094753 0.84 PARP1 (0.30) —
SCHEMBL26132966 0.84 — —
SCHEMBL26094915 0.84 — —
SCHEMBL26133268 0.83 MAPK1 (0.33) MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023066350-A1 CRBN E3 LIGASE LIGAND COMPOUND, PROTEIN DEGRADING AGENT DEVELOPED ON THE BASIS OF LIGAND COMPOUND, AND THEIR APPLICATIONS 标新生物医药科技(上海)有限公司 2023-04-27 — — WO claimed
Send feedback